Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Latent Tuberculosis

moxifloxacin has been researched along with Latent Tuberculosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Aguado, JM; Calvo, J; Cambra, F; Caso, O; Fernández-Ruiz, M; García-Sesma, Á; Hernández-Jimenez, P; Jimenez, C; Justo, I; Loinaz, C; López-Medrano, F; Lumbreras, C; Manrique, A; Marcacuzco, A; San Juan, R; Silva, JT1
Brij, SO; Mamo, JP1
Darley, DR; Glanville, AR; Goeman, EE; Jensen, TO; Marriott, DJ; Shaw, K1
Fattorini, L; Filippini, P; Iona, E; Neyrolles, O; Peyron, P; Piccaro, G1

Other Studies

4 other study(ies) available for moxifloxacin and Latent Tuberculosis

ArticleYear
Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single-Center Prospective Study.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2021, Volume: 27, Issue:6

    Topics: Antitubercular Agents; Humans; Latent Tuberculosis; Liver Transplantation; Moxifloxacin; Mycobacterium tuberculosis; Prospective Studies

2021
Treating tuberculosis in the elderly population: a lesson in multi-disciplinary care.
    Scottish medical journal, 2013, Volume: 58, Issue:4

    Topics: Aged, 80 and over; Antitubercular Agents; Aza Compounds; Drug Interactions; England; Fluoroquinolones; Humans; Incidence; Latent Tuberculosis; Male; Moxifloxacin; Pharmacists; Quinolines; Radiography, Thoracic; Recurrence; Referral and Consultation; Treatment Outcome

2013
Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Adult; Allografts; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antitubercular Agents; Bacteremia; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Immunosuppression Therapy; Isoniazid; Latent Tuberculosis; Lung Transplantation; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Pseudomonas aeruginosa; Rifampin; Tissue Donors; Tuberculosis, Pulmonary

2016
Activity of drug combinations against dormant Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: 3T3 Cells; Adipocytes; Amikacin; Animals; Antitubercular Agents; Aza Compounds; Capreomycin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Latent Tuberculosis; Metronidazole; Mice; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin

2010